Skip to main content
SpringerLink
Log in

Hyperprolactinemia and Pituitary Causes of Amenorrhea

  • Chapter
  • First Online:
Amenorrhea

Part of the book series: Contemporary Endocrinology ((COE))

  • 1354 Accesses

Abstarct

Pituitary causes of amenorrhea constitute approximately 18% of cases of secondary amenorrhea but only approximately 7% of cases of primary amenorrhea [1]. The most common pituitary cause of amenorrhea is hyperprolactinemia constituting 80% of all pituitary causes of secondary amenorrhea and approximately 15% of cases of secondary amenorrhea due to any cause [2]. In this chapter, we review the causes, clinical presentation, diagnostic evaluation, and current treatment strategies for amenorrhea due to hyperprolactinemia and other pituitary disorders. We present an illustrative case of secondary amenorrhea due to a pituitary cause.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Reindollar RH, Byrd JR, McDonough PG (1981) Delayed sexual development: a study of 252 patients. Am J Obstet Gynecol 140:371–380

    PubMed  CAS  Google Scholar 

  2. Reindollar RH, Novak M, Tho SP, McDonough PG (1986) Adult-onset amenorrhea: a study of 262 patients. Am J Obstet Gynecol 155:531–543

    PubMed  CAS  Google Scholar 

  3. Kleinberg DL, Noel GL, Frantz AG (1977) Galactorrhea: a study of 235 cases, including 48 with pituitary tumors. N Engl J Med 296:589–600

    Article  PubMed  CAS  Google Scholar 

  4. Tyson JE, Hwang P, Guyda H, Friesen HG (1972) Studies of prolactin secretion in human pregnancy. Am J Obstet Gynecol 113:14–20

    PubMed  CAS  Google Scholar 

  5. Jarrell J, Franks S, McInnes R, Gemayel K, Guyda H, Arronet GH, Naftolin F (1980) Breast examination does not elevate serum prolactin. Fertil Steril 33:49–51

    PubMed  CAS  Google Scholar 

  6. Gibney J, Smith TP, McKenna TJ (2005) Clinical relevance of macroprolactin. Clin Endocrinol (Oxf) 62:633–643

    Article  CAS  Google Scholar 

  7. Hattori N, Inagaki C (1997) Anti-prolactin (PRL) autoantibodies cause asymptomatic hyperprolactinemia: bioassay and clearance studies of PRL-immunoglobulin G complex. J Clin Endocrinol Metab 82:3107–3110

    Article  PubMed  CAS  Google Scholar 

  8. Leslie H, Courtney CH, Bell PM, Hadden DR, McCance DR, Ellis PK, Sheridan B, Atkinson AB (2001) Laboratory and clinical experience in 55 patients with macroprolactinemia identified by a simple polyethylene glycol precipitation method. J Clin Endocrinol Metab 86:2743–2746

    Article  PubMed  CAS  Google Scholar 

  9. Vallette-Kasic S, Morange-Ramos I, Selim A, Gunz G, Morange S, Enjalbert A, Martin PM, Jaquet P, Brue T (2002) Macroprolactinemia revisited: a study on 106 patients. J Clin Endocrinol Metab 87:581–588

    Article  PubMed  CAS  Google Scholar 

  10. Olukoga AO, Kane JW (1999) Macroprolactinaemia: validation and application of the polyethylene glycol precipitation test and clinical characterization of the condition. Clin Endocrinol (Oxf) 51:119–126

    Article  CAS  Google Scholar 

  11. Rivera JL, Lal S, Ettigi P, Hontela S, Muller HF, Friesen HG (1976) Effect of acute and chronic neuroleptic therapy on serum prolactin levels in men and women of different age groups. Clin Endocrinol (Oxf) 5:273–282

    Article  CAS  Google Scholar 

  12. David SR, Taylor CC, Kinon BJ, Breier A (2000) The effects of olanzapine, risperidone, and haloperidol on plasma prolactin levels in patients with schizophrenia. Clin Ther 22:1085–1096

    Article  PubMed  CAS  Google Scholar 

  13. Molitch ME (2008) Drugs and prolactin. Pituitary 11:209–218

    Article  PubMed  CAS  Google Scholar 

  14. Meltzer H, Bastani B, Jayathilake K, Maes M (1997) Fluoxetine, but not tricyclic antidepressants, potentiates the 5-hydroxytryptophan-mediated increase in plasma cortisol and prolactin secretion in subjects with major depression or with obsessive compulsive disorder. Neuropsychopharmacology 17:1–11

    Article  PubMed  CAS  Google Scholar 

  15. Steiner J, Cassar J, Mashiter K, Dawes I, Fraser TR, Breckenridge A (1976) Effects of methyldopa on prolactin and growth hormone. Br Med J 1:1186–1188

    Article  PubMed  CAS  Google Scholar 

  16. Fearrington EL, Rand CH Jr, Rose JD (1983) Hyperprolactinemia-galactorrhea induced by verapamil. Am J Cardiol 51:1466–1467

    Article  PubMed  CAS  Google Scholar 

  17. Kelley SR, Kamal TJ, Molitch ME (1996) Mechanism of verapamil calcium channel blockade-induced hyperprolactinemia. Am J Physiol 270:E96–E100

    PubMed  CAS  Google Scholar 

  18. Yen SS, Ehara Y, Siler TM (1974) Augmentation of prolactin secretion by estrogen in hypogonadal women. J Clin Invest 53:652–655

    Article  PubMed  CAS  Google Scholar 

  19. Hentges S, Sarkar DK (2001) Transforming growth factor-beta regulation of estradiol-induced prolactinomas. Front Neuroendocrinol 22:340–363

    Article  PubMed  CAS  Google Scholar 

  20. Walker JD, Grossman A, Anderson JV, Ur E, Trainer PJ, Benn J, Lowy C, Sonksen PH, Plowman PN, Lowe DG et al (1993) Malignant prolactinoma with extracranial metastases: a report of three cases. Clin Endocrinol (Oxf) 38:411–419

    Article  CAS  Google Scholar 

  21. Delgrange E, Trouillas J, Maiter D, Donckier J, Tourniaire J (1997) Sex-related difference in the growth of prolactinomas: a clinical and proliferation marker study. J Clin Endocrinol Metab 82:2102–2107

    Article  PubMed  CAS  Google Scholar 

  22. Morley JE, Dawson M, Hodgkinson H, Kalk WJ (1977) Galactorrhea and hyperprolactinemia associated with chest wall injury. J Clin Endocrinol Metab 45:931–935

    Article  PubMed  CAS  Google Scholar 

  23. Lieberman SA, Oberoi AL, Gilkison CR, Masel BE, Urban RJ (2001) Prevalence of neuroendocrine dysfunction in patients recovering from traumatic brain injury. J Clin Endocrinol Metab 86:2752–2756

    Article  PubMed  CAS  Google Scholar 

  24. Aimaretti G, Ambrosio MR, Di Somma C, Gasperi M, Cannavo S, Scaroni C, Fusco A, Del Monte P, De Menis E, Faustini-Fustini M, Grimaldi F, Logoluso F, Razzore P, Rovere S, Benvenga S, Degli Uberti EC, De Marinis L, Lombardi G, Mantero F, Martino E, Giordano G, Ghigo E (2005) Residual pituitary function after brain injury-induced hypopituitarism: a prospective 12-month study. J Clin Endocrinol Metab 90:6085–6092

    Article  PubMed  CAS  Google Scholar 

  25. Snyder PJ, Jacobs LS, Utiger RD, Daughaday WH (1973) Thyroid hormone inhibition of the prolactin response to thyrotropin-releasing hormone. J Clin Invest 52:2324–2329

    Article  PubMed  CAS  Google Scholar 

  26. Groff TR, Shulkin BL, Utiger RD, Talbert LM (1984) Amenorrhea-galactorrhea, hyperprolactinemia, and suprasellar pituitary enlargement as presenting features of primary hypothyroidism. Obstet Gynecol 63:86S–89S

    PubMed  CAS  Google Scholar 

  27. Sievertsen GD, Lim VS, Nakawatase C, Frohman LA (1980) Metabolic clearance and secretion rates of human prolactin in normal subjects and in patients with chronic renal failure. J Clin Endocrinol Metab 50:846–852

    Article  PubMed  CAS  Google Scholar 

  28. Gomez F, Reyes FI, Faiman C (1977) Nonpuerperal galactorrhea and hyperprolactinemia. Clinical findings, endocrine features and therapeutic responses in 56 cases. Am J Med 62:648–660

    Article  PubMed  CAS  Google Scholar 

  29. Kooy A, de Greef WJ, Vreeburg JT, Hackeng WH, Ooms MP, Lamberts SW, Weber RF (1990) Evidence for the involvement of corticotropin-releasing factor in the inhibition of gonadotropin release induced by hyperprolactinemia. Neuroendocrinology 51:261–266

    Article  PubMed  CAS  Google Scholar 

  30. Corenblum B, Pairaudeau N, Shewchuk AB (1976) Prolactin hypersecretion and short luteal phase defects. Obstet Gynecol 47:486–488

    PubMed  CAS  Google Scholar 

  31. Seppala M, Ranta T, Hirvonen E (1976) Hyperprolactinaemia and luteal insufficiency. Lancet 1:229–230

    Article  PubMed  CAS  Google Scholar 

  32. Biller BM, Baum HB, Rosenthal DI, Saxe VC, Charpie PM, Klibanski A (1992) Progressive trabecular osteopenia in women with hyperprolactinemic amenorrhea. J Clin Endocrinol Metab 75:692–697

    Article  PubMed  CAS  Google Scholar 

  33. Kemmann E, Jones JR (1983) Hyperprolactinemia and headaches. Am J Obstet Gynecol 145:668–671

    PubMed  CAS  Google Scholar 

  34. Bosco D, Belfiore A, Fava A, De Rose M, Plastino M, Ceccotti C, Mungari P, Iannacchero R, Lavano A (2008) Relationship between high prolactin levels and migraine attacks in patients with microprolactinoma. J Headache Pain 9:103–107

    Article  PubMed  CAS  Google Scholar 

  35. Webster J, Piscitelli G, Polli A, Ferrari CI, Ismail I, Scanlon MF (1994) A comparison of cabergoline and bromocriptine in the treatment of hyperprolactinemic amenorrhea. Cabergoline Comparative Study Group. N Engl J Med 331:904–909

    Article  PubMed  CAS  Google Scholar 

  36. Bronstein MD, Salgado LR, de Castro Musolino NR (2002) Medical management of pituitary adenomas: the special case of management of the pregnant woman. Pituitary 5:99–107

    Article  PubMed  CAS  Google Scholar 

  37. Schade R, Andersohn F, Suissa S, Haverkamp W, Garbe E (2007) Dopamine agonists and the risk of cardiac-valve regurgitation. N Engl J Med 356:29–38

    Article  PubMed  CAS  Google Scholar 

  38. Zanettini R, Antonini A, Gatto G, Gentile R, Tesei S, Pezzoli G (2007) Valvular heart disease and the use of dopamine agonists for Parkinson’s disease. N Engl J Med 356:39–46

    Article  PubMed  CAS  Google Scholar 

  39. Kars M, Delgado V, Holman ER, Feelders RA, Smit JW, Romijn JA, Bax JJ, Pereira AM (2008) Aortic valve calcification and mild tricuspid regurgitation but no clinical heart disease after 8 years of dopamine agonist therapy for prolactinoma. J Clin Endocrinol Metab 93:3348–3356

    Article  PubMed  CAS  Google Scholar 

  40. Colao A, Galderisi M, Di Sarno A, Pardo M, Gaccione M, D’Andrea M, Guerra E, Pivonello R, Lerro G, Lombardi G (2008) Increased prevalence of tricuspid regurgitation in patients with prolactinomas chronically treated with cabergoline. J Clin Endocrinol Metab 93:3777–3784

    Article  PubMed  CAS  Google Scholar 

  41. Bogazzi F, Manetti L, Raffaelli V, Lombardi M, Rossi G, Martino E (2008) Cabergoline therapy and the risk of cardiac valve regurgitation in patients with hyperprolactinemia: a meta-analysis from clinical studies. J Endocrinol Invest 31:1119–1123

    PubMed  CAS  Google Scholar 

  42. Vallette S, Serri K, Rivera J, Santagata P, Delorme S, Garfield N, Kahtani N, Beauregard H, Aris-Jilwan N, Houde G, Serri O (2008) Long-term cabergoline therapy is not associated with valvular heart disease in patients with prolactinomas. Pituitary 12(3):153–157

    Article  Google Scholar 

  43. Devin JK, Lakhani VT, Byrd BF 3rd, Blevins LS Jr (2008) Prevalence of valvular heart ­disease in a cohort of patients taking cabergoline for management of hyperprolactinemia. Endocr Pract 14:672–677

    PubMed  Google Scholar 

  44. Nachtigall LB, Valassi E, Lo J, McCarty D, Passeri J, Biller BM, Miller KK, Utz A, Grinspoon S, Lawson EA, Klibanski A (2009) Gender effects on cardiac valvular function in hyperprolactinaemic patients receiving cabergoline: a retrospective study. Clin Endocrinol (Oxf) 72(1):53–58

    Article  Google Scholar 

  45. Kelestimur F (2003) Sheehan’s syndrome. Pituitary 6:181–188

    Article  PubMed  Google Scholar 

  46. Feinberg EC, Molitch ME, Endres LK, Peaceman AM (2005) The incidence of Sheehan’s syndrome after obstetric hemorrhage. Fertil Steril 84:975–979

    Article  PubMed  Google Scholar 

  47. Zargar AH, Singh B, Laway BA, Masoodi SR, Wani AI, Bashir MI (2005) Epidemiologic aspects of postpartum pituitary hypofunction (Sheehan’s syndrome). Fertil Steril 84:523–528

    Article  PubMed  Google Scholar 

  48. Thodou E, Asa SL, Kontogeorgos G, Kovacs K, Horvath E, Ezzat S (1995) Clinical case seminar: lymphocytic hypophysitis: clinicopathological findings. J Clin Endocrinol Metab 80:2302–2311

    Article  PubMed  CAS  Google Scholar 

  49. Kristof RA, Van Roost D, Klingmuller D, Springer W, Schramm J (1999) Lymphocytic hypophysitis: non-invasive diagnosis and treatment by high dose methylprednisolone pulse therapy? J Neurol Neurosurg Psychiatry 67:398–402

    Article  PubMed  CAS  Google Scholar 

  50. Kelly TM, Edwards CQ, Meikle AW, Kushner JP (1984) Hypogonadism in hemochromatosis: reversal with iron depletion. Ann Intern Med 101:629–632

    PubMed  CAS  Google Scholar 

  51. Stuart CA, Neelon FA, Lebovitz HE (1978) Hypothalamic insufficiency: the cause of hypopituitarism in sarcoidosis. Ann Intern Med 88:589–594

    PubMed  CAS  Google Scholar 

  52. Lam KS, Sham MM, Tam SC, Ng MM, Ma HT (1993) Hypopituitarism after tuberculous meningitis in childhood. Ann Intern Med 118:701–706

    PubMed  CAS  Google Scholar 

  53. Kaltsas GA, Powles TB, Evanson J, Plowman PN, Drinkwater JE, Jenkins PJ, Monson JP, Besser GM, Grossman AB (2000) Hypothalamo-pituitary abnormalities in adult patients with langerhans cell histiocytosis: clinical, endocrinological, and radiological features and response to treatment. J Clin Endocrinol Metab 85:1370–1376

    Article  PubMed  CAS  Google Scholar 

  54. Snyder PJ, Fowble BF, Schatz NJ, Savino PJ, Gennarelli TA (1986) Hypopituitarism following radiation therapy of pituitary adenomas. Am J Med 81:457–462

    Article  PubMed  CAS  Google Scholar 

  55. Sudhakar N, Ray A, Vafidis JA (2004) Complications after trans-sphenoidal surgery: our experience and a review of the literature. Br J Neurosurg 18:507–512

    PubMed  CAS  Google Scholar 

  56. Barker FG 2nd, Klibanski A, Swearingen B (2003) Transsphenoidal surgery for pituitary tumors in the United States, 1996-2000: mortality, morbidity, and the effects of hospital and surgeon volume. J Clin Endocrinol Metab 88:4709–4719

    Article  PubMed  CAS  Google Scholar 

  57. Constine LS, Woolf PD, Cann D, Mick G, McCormick K, Raubertas RF, Rubin P (1993) Hypothalamic-pituitary dysfunction after radiation for brain tumors. N Engl J Med 328:87–94

    Article  PubMed  CAS  Google Scholar 

  58. Agha A, Sherlock M, Brennan S, O’Connor SA, O’Sullivan E, Rogers B, Faul C, Rawluk D, Tormey W, Thompson CJ (2005) Hypothalamic-pituitary dysfunction after irradiation of nonpituitary brain tumors in adults. J Clin Endocrinol Metab 90:6355–6360

    Article  PubMed  CAS  Google Scholar 

  59. Benvenga S, Campenni A, Ruggeri RM, Trimarchi F (2000) Clinical review 113: hypopituitarism secondary to head trauma. J Clin Endocrinol Metab 85:1353–1361

    Article  PubMed  CAS  Google Scholar 

  60. Kelberman D, Dattani MT (2007) Hypopituitarism oddities: congenital causes. Horm Res 68(suppl 5):138–144

    Article  PubMed  Google Scholar 

  61. Sobrinho LG (2003) Prolactin, psychological stress and environment in humans: adaptation and maladaptation. Pituitary 6:35–39

    Article  PubMed  Google Scholar 

  62. Kruger TH, Haake P, Hartmann U, Schedlowski M, Exton MS (2002) Orgasm-induced prolactin secretion: feedback control of sexual drive? Neurosci Biobehav Rev 26:31–44

    Article  PubMed  CAS  Google Scholar 

  63. Quigley ME, Ishizuka B, Ropert JF, Yen SS (1982) The food-entrained prolactin and cortisol release in late pregnancy and prolactinoma patients. J Clin Endocrinol Metab 54:1109–1112

    Article  PubMed  CAS  Google Scholar 

  64. Molitch ME (1985) Pregnancy and the hyperprolactinemic woman. N Engl J Med 312:1364–1370

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Neuroendocrine Clinical Center unit, Massachusetts General Hospital and Harvard Medical School, Boston, MA, 02114, USA

    Lisa B. Nachtigall

Authors
  1. Pouneh Fazeli
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Lisa B. Nachtigall
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Lisa B. Nachtigall .

Editor information

Editors and Affiliations

  1. , Department of Obstetrics and Gynecology, University of Colorado Denver School of, Academic Office Building 1, Room 4010, Aurora, 80045, Colorado, USA

    Nanette F. Santoro

  2. , Department of Obstetrics and Gynecology, Albert Einstein College of Medicine, 1300 Morris Park Ave, Ullman 1211, Bronx, 10461, New York, USA

    Genevieve Neal-Perry

Rights and permissions

Reprints and permissions

Copyright information

© 2010 Humana Press

About this chapter

Cite this chapter

Fazeli, P., Nachtigall, L.B. (2010). Hyperprolactinemia and Pituitary Causes of Amenorrhea. In: Santoro, N., Neal-Perry, G. (eds) Amenorrhea. Contemporary Endocrinology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-60327-864-5_6

Download citation

  • DOI: https://doi.org/10.1007/978-1-60327-864-5_6

  • Published:

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-60327-863-8

  • Online ISBN: 978-1-60327-864-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation